Page last updated: 2024-12-10
bemp phosphazene
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
BEMP phosphazene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 3513851 |
| SCHEMBL ID | 185023 |
| MeSH ID | M0299792 |
Synonyms (32)
| Synonym |
|---|
| 2-tert-butylimino-2-diethylamino-1,3-diethyl-perhydro-1,3,2-diazaphosphorine |
| df15j146qi , |
| unii-df15j146qi |
| bemp phosphazene |
| AKOS015894695 |
| 2-tert-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine |
| 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine |
| bemp |
| 98015-45-3 |
| 2-(tert-butylimino)-n,n-diethyl-1,3-dimethyl-1,3,2lambda(5)-diazaphosphinan-2-amine |
| 2-(tert-butylimino)-n,n-diethyl-1,3-dimethyl-1,3,2lambda5-diazaphosphinan-2-amine |
| 2-t-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine |
| 2-(tert-butylimino)-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine |
| 2-tert-butylimino-2-diethylamino-1,3-dimethyl-perhydro -1,3,2-diaza-phosphorine |
| VSCBATMPTLKTOV-UHFFFAOYSA-N |
| 2-tert-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diaza-phosphorine |
| 2-tert-butylimino-2-diethylamino-1,3-dimethyl-1,3,2-diazaphosphorinane |
| 2-tert.-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine |
| SCHEMBL185023 |
| DTXSID50243369 |
| 2-tert-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorin |
| mfcd00043143 |
| 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine, purum, >=98.0% (gc) |
| BBL103546 |
| STL557356 |
| 2-(tert-butylimino)-n,n-diethyl-1,3-dimethyl-1,3,2lambda~5~-diazaphosphinan-2-amine |
| FT-0730193 |
| CS-0204484 |
| 2-tert-butylimino-n,n-diethyl-1,3-dimethyl-1,3,2lambda5-diazaphosphinan-2-amine |
| Q27276359 |
| 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2 diazaphosphorine |
| A915375 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 13.13
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.13) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||